Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Topic:Epidemiology
Epidemiology in horses involves the study of the distribution and determinants of health-related states and events in equine populations. It encompasses the investigation of patterns, causes, and effects of diseases and health conditions within horse populations. This field of study aims to identify risk factors for disease and targets for preventive healthcare. Key components of equine epidemiology include disease surveillance, outbreak investigation, and the study of disease dynamics within herds or regions. Research in this area often focuses on infectious diseases, zoonotic diseases, and the impact of environmental factors on equine health. This page compiles peer-reviewed research studies and scholarly articles that explore various aspects of epidemiology in horses, including disease prevalence, transmission pathways, and strategies for disease prevention and control.
Equine arteritis virus. Equine arteritis virus (EAV) is the causative agent of equine viral arteritis (EVA), a respiratory and reproductive disease of equids. There has been significant recent progress in understanding the molecular biology of EAV and the pathogenesis of its infection in horses. In particular, the use of contemporary genomic techniques, along with the development and reverse genetic manipulation of infectious cDNA clones of several strains of EAV, has generated significant novel information regarding the basic molecular biology of the virus. Therefore, the objective of this review is to summarize cur...
Epidemiological and genetic study of exertional rhabdomyolysis in a Warmblood horse family in Switzerland. Exertional rhabdomyolysis (ER) and its familial basis in Warmblood horses is incompletely understood. Objective: To describe the case details, clinical signs and management of ER-affected Warmblood horses from a family with a high prevalence of ER, to determine if histopathological signs of polysaccharide storage myopathy (PSSM) and the glycogen synthase (GYS1) mutation are associated with ER in this family, and to investigate potential risk factors for development of ER. Methods: A family consisting of a sire with ER and 71 of his descendants was investigated. History of episodes of ER, husba...
Causes of horse-related injuries in a rural western community. To determine the causes of horse-related injuries in a rural western community. Methods: Prospective identification of persons with horse-related injuries and retrospective interviews with patients or witnesses to determine causes. Methods: A small rural community in Alberta where the western style of riding predominates. Methods: All patients presenting to two family medicine clinics or to the Sundre General Hospital emergency department. Methods: Factors contributing to the injury as recalled by patients or witnesses, and characteristics of the persons, horses, and injuries. Results: Two thi...
Risk factors for Clostridium piliforme infection in foals. To determine risk factors for Clostridium piliforme infection in neonatal foals on a Thoroughbred breeding farm in California. Methods: Case-control and retrospective cohort studies. Methods: 322 neonatal Thoroughbred foals either born on the study farm or born elsewhere but traveled to the farm with their dam during the 1998, 1999, and 2000 breeding seasons. Methods: Mare and foal records from 1998, 1999, and 2000 were examined, using case-control design methods to determine variables associated with increased risk of C. piliforme infection in foals. Important risk factors identified in the c...
Prevalence of large endoparasites at necropsy in horses infected with Population B small strongyles in a herd established in Kentucky in 1966. Two closed horse herds (Old Lot 4 and Field 24), infected since 1966 with Population B small strongyles resistant to thiabendazole (TBZ) and phenothiazine (PTZ), were terminated in February, March, and May, 2005. At necropsy, only the large endoparasites were identified and counted. The number of horses on pasture was 14 (239 days of age to 23 years old) for Old Lot 4 and two (3 to 20 years old) for Field 24. The time of the last antiparasitic treatment, relative to the year (2005) of necropsy, was 26 years for Old Lot 4 and 9 years for Field 24 horses. Gasterophilus intestinalis third instars...
Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine. A clinical evaluation of a new, purified, heat-treated equine rabies immunoglobulin (PHT-Erig), F(ab')2 preparation, was carried out in Thailand and in the Philippines-two countries where rabies is endemic. An initial prospective, randomised, controlled trial (Study 1), compared the safety and pharmacokinetics (serum concentrations of rabies antibodies) after administration either of PHT-Erig or of a commercially-available, equine rabies immune globulin (Erig PMC). A second trial (Study 2) simulated post-exposure rabies prophylaxis by using a reference cell culture vaccine, the purified Vero-c...
[Anoplocephala sp. prevalence in equines at the Sociedade Hípica Paranaense, Curitiba, PR]. Anoplocephala sp. parasites are among the most frequent tapeworms in equines and are associated with intestinal infections. This survey had the objective to verify Anoplocephala sp. prevalence at Sociedade Hípica Paranaense (SHPr). The animals were treated with ivermectin, which does not have efficacy against Anoplocephala sp.. To determine whether eggs of Anoplocephala sp. were present, a modified centrifugal flotation technique was used and also eggs per gram of faeces (EPG). None of the samples showed Anoplocephala sp. eggs and only 11% of the animals had positive values for EPG. The resul...
The Horserace Betting Levy Board codes of practice: past and present. The 2025 horse breeding season sees the release of the 49th consecutive edition of the Horserace Betting Levy Board Codes of Practice for the prevention and control of specified infectious diseases. In this article, Sidney Ricketts, James Crabtree and Richard Newton describe how the first edition of the codes came about in 1977 and their evolution over the past five decades.
